Ineo-vac-t01 (Not yet branded)
Other Medications
Description
Ineo-Vac-T01 is a personalized T-cell immunotherapy designed for treatment of advanced colorectal cancer. This therapeutic approach involves extracting and modifying a patient's own T-cells to enhance their ability to recognize and attack colorectal cancer cells. The treatment represents a form of adoptive cell therapy that aims to harness the patient's immune system against tumor-specific antigens.
Mechanism of Action
The therapy works by collecting T-cells from the patient, genetically modifying or expanding them ex vivo to improve their tumor recognition capabilities, and then reinfusing them back into the patient. These enhanced T-cells are designed to target specific neoantigens present on the patient's colorectal cancer cells, potentially leading to improved immune-mediated tumor destruction.
Molecular Targets
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
Quick Info
| Brand Name | Not yet branded |
| Category | Other Medications |
 Status | Experimental |
| Administration | IV |
| Clinical Trials | 1 |
Related Medications
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.